MedPath

Cefuromax

Brand Name: Cefuromax

Generic Name: Cefuroxime (as sodium)

Active
Registration Number

DRP-11361-02

Dosage Form

Powder for Injection (IM/IV)

Issuance Date

March 31, 2023

Expiry Date

March 4, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength750mg
PackagingType II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-Off Cap x 1's + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefuroxime (as sodium)Active
Monograph: cefuroxime (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform